Top Markets
#1 Black Phoenix Black Phoenix +733.82%
#2 MiL.k Alliance MiL.k Alliance +29.84%
#3 Biconomy Biconomy +24.27%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.03%
#5 THORChain THORChain +19.51%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +15.95%
#7 Moolah Moolah +14.73%
#8 THORChain Yield THORChain Yield +14.31%
#9 Tokamak Network Tokamak Network +12.76%
#10 XPIN Network XPIN Network +12.32%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Sam Chun Dang Pharm. Co., Ltd Sam Chun Dang Pharm. Co., Ltd

Sam Chun Dang Pharm. Co., Ltd

000250
Rank in Stocks #5349
Sam Chun Dang Pharm Co., Ltd. is a pharmaceutical company that develops and... Sam Chun Dang Pharm Co., Ltd. is a pharmaceutical company that develops and produces a wide variety of medications. Its product range features antibiotics, treatments for cardiovascular and respiratory conditions, drugs for the digestive system and ophthalmic use, as well as anti-inflammatory agents. The company was founded on December 29, 1943, and its main operations are based in Hwaseong-si, South Korea.
Share Price
$118.66
Market Cap
$2.78B
Change (1 day)
0.29%
Change (1 year)
-14.79%
Country
KR
Trade Sam Chun Dang Pharm. Co., Ltd (000250)

Category

Healthcare
P/E ratio for Sam Chun Dang Pharm. Co., Ltd (000250)
P/E ratio as of 2026 TTM: 0
According to Sam Chun Dang Pharm. Co., Ltd latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Sam Chun Dang Pharm. Co., Ltd from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 24.32 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 220.13 -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 31.46 -
HK
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.